Results

Total Results: 404 records

Showing results for "vascular".

141. Self-Measured Blood Pressure Monitoring: Comparative Effectiveness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/measuring-blood-pressure/research

142. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - The total incidence of deaths from vascular or unknown causes, nonfatal myocardial infarctions, and … nonfatal cerebrovascular accidents, which are possible effects from systemic vascular endothelial … The incidence of serious adverse events potentially related to systemic vascular endothelial growth … Vascular endothelial growth factor A. In: GeneCards [internet]. … Clinical policy bulletin: vascular endothelial growth factor inhibitors for ocular neovascularization

143. Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research-protocol

144. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research

145. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-artery-stenting-future/research

146. Neurothrombectomy Devices for Treatment of Acute Ischemic Stroke | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ischemic-stroke-treatment/technical-brief

147. Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol

148. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay-future/research

149. Anticoagulation for Venous Thromboembolic Events in Patients with Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-venous-thrombosis-anticoagulation/abstract

150. Addressing Knowledge Gaps in the Treatment of Hypertension Using ACE/ARB Therapies | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hypertension-treatment-knowledge-gaps/abstract

151. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol

152. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
     January 01, 2022 - 0.32 to 0.71) Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50) Vascular

153. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - or transient ischemic attack, congenital heart disorder, coronary artery anomaly, and peripheral vascular … Age-specific relevance of usual blood pressure to vascular mortality: a meta- analysis of individual … Congenital heart disorder 331 0.2% 556 0.2% Coronary artery anomaly 66 0.0% 89 0.0% Peripheral vascular … 849.5 1.1% Coronary artery anomaly 16.3 0.2% 7.6 0.1% 14.4 0.2% 79.3 0.4% 154.9 0.2% Peripheral vascular … 3798.7 20 5.27 1.02 0.65-1.60 Coronary artery anomaly 656.6 14 21.32 1.58 0.92-2.70 Peripheral vascular

154. Real World Effectiveness of Carotid Artery Stenting (CAS) in Medicare Patients | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-stents-effectiveness/abstract

155. Comparative Effectiveness of Noninvasive Technologies for the Diagnosis of Coronary Artery Disease (CAD) in Women | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-diagnosis/research-protocol

156. Comparative Effectiveness of Treatment Strategies for Women With Coronary Artery Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-treatment/research-protocol

157. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-2007/research-2007-1

158. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - o CVD clinical outcomes  Cardiac events or symptoms  Cerebrovascular events  Peripheral vascular … myocardial infarction, angina]; cerebrovascular events [stroke; transient ischemic attacks]; peripheral vascular

159. Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-diagnosis/research

160. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stroke-atrial-fibrillation/research